Literature DB >> 11821094

Thrombophilia is common in women with idiopathic pregnancy loss and is associated with late pregnancy wastage.

Galit Sarig1, Johnny S Younis, Ron Hoffman, Naomi Lanir, Zeev Blumenfeld, Benjamin Brenner.   

Abstract

OBJECTIVE: To describe the characteristics of thrombophilia in women with idiopathic pregnancy loss.
DESIGN: Prospective observational study.
SETTING: Tertiary referral center in a teaching academic hospital. PATIENT(S): One hundred forty-five patients with repeated pregnancy loss and 145 matched controls. INTERVENTION(S): Prospective assessment of thrombophilia in patients and controls. MAIN OUTCOME MEASURE(S): Prevalence of activated protein C (APC) resistance, protein C, protein S, and antithrombin III deficiencies, antiphospholipid antibodies, factor V Leiden, factor II G20210A, and MTHFR C677T mutations. RESULT(S): At least one thrombophilic defect was found in 66% of study group patients compared with 28% in control group patients. Combined thrombophilic defects were documented in 21% of women with pregnancy loss compared with 5.5% of control patients. Late pregnancy wastage occurred more frequently in women with thrombophilia compared with women without thrombophilia (160/429 [37%] vs. 39/162 [24%], respectively). APC resistance was documented in 39% of women with pregnancy loss compared with 3% of the control patients. APC resistance without factor V Leiden mutation was documented in 18% of women with pregnancy loss compared with none of the controls. While factor V Leiden mutation was more common in women with pregnancy loss (25% vs. 7.6%), factor II G20210A and homozygosity for MTHFR C677T contributed to pregnancy loss only in the presence of other thrombophilia. CONCLUSION(S): Thrombophilia was found in the majority (66%) of women with idiopathic pregnancy loss. APC resistance with or without factor V Leiden mutation is the most common thrombophilic defect, and combined thrombophilia is a frequent finding in women with pregnancy loss. Thrombophilia is associated with increased frequency of late pregnancy wastage.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11821094     DOI: 10.1016/s0015-0282(01)02971-5

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  27 in total

1.  Venous thromboembolism and pregnancy.

Authors:  Maristella D'Uva; Pierpaolo Di Micco; Ida Strina; Giuseppe De Placido
Journal:  J Blood Med       Date:  2010-03-03

2.  The cost-benefit ratio of screening pregnant women for thrombophilia.

Authors:  Gian Luca Salvagno; Giuseppe Lippi; Massimo Franchini; Giovanni Targher; Martina Montagnana; Massimo Franchi; Gian Cesare Guidi
Journal:  Blood Transfus       Date:  2007-11       Impact factor: 3.443

Review 3.  Angiotensin-converting enzyme insertion/deletion (I/D) polymorphisms and recurrent pregnancy loss: a meta-analysis.

Authors:  Chen Yang; Wu Fangfang; Li Jie; Yang Yanlong; Wang Jie; Liang Xuefei; Zhang Xuerong; Hu Yanling
Journal:  J Assist Reprod Genet       Date:  2012-10-07       Impact factor: 3.412

Review 4.  Anticoagulant therapy and pregnancy.

Authors:  Aiko Makino; Mayumi Sugiura-Ogasawara
Journal:  Reprod Med Biol       Date:  2008-02-01

5.  Genetic evaluation and counseling of couples with recurrent miscarriage: recommendations of the National Society of Genetic Counselors.

Authors:  Mercy Y Laurino; Robin L Bennett; Devki S Saraiya; Lisa Baumeister; Debra Lochner Doyle; Kathleen Leppig; Barbara Pettersen; Robert Resta; Larry Shields; Stefanie Uhrich; Elizabeth A Varga; Wendy H Raskind
Journal:  J Genet Couns       Date:  2005-06       Impact factor: 2.537

6.  Recurrent pregnancy loss in a subject with heterozygote factor V Leiden mutation; a case report.

Authors:  Reza Ebrahimzadeh-Vesal; Roza Azam; Arvin Ghazarian; Mogge Hajesmaeili; Najmeh Ranji; Mohammad Reza Ezzati; Mehrdad Sadri; Mohammad Ali Mohammadi; Siamak Khavandi
Journal:  Rep Biochem Mol Biol       Date:  2014-04

7.  Recurrent pregnancy loss and thrombophilia.

Authors:  Maristella D'Uva; Pierpaolo Di Micco; Ida Strina; Giuseppe De Placido
Journal:  J Clin Med Res       Date:  2010-02-26

8.  Risk for early pregnancy loss by factor XIII Val34Leu: the impact of fibrinogen concentration.

Authors:  Astrid Dossenbach-Glaninger; Mick van Trotsenburg; Christian Oberkanins; Johanna Atamaniuk
Journal:  J Clin Lab Anal       Date:  2013-11       Impact factor: 2.352

9.  Prothrombin gene variants in non-Caucasians with fetal loss and intrauterine growth retardation.

Authors:  Iris Schrijver; Tiffanee J Lenzi; Carol D Jones; Marla J Lay; Maurice L Druzin; James L Zehnder
Journal:  J Mol Diagn       Date:  2003-11       Impact factor: 5.568

10.  Etiology of hypercoagulable state in women with recurrent fetal loss without other causes of miscarriage from Southern Italy: new clinical target for antithrombotic therapy.

Authors:  Maristella D'Uva; Pierpaolo Di Micco; Ida Strina; Antonio Ranieri; Carlo Alviggi; Antonio Mollo; Francesca Fabozzi; Lucia Cacciapuoti; Maria Teresa Scotto di Frega; Mariateresa Iannuzzo; Giuseppe De Placido
Journal:  Biologics       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.